BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35655917)

  • 1. Bioinformatics Study Identified EGF as a Crucial Gene in Papillary Renal Cell Cancer.
    Qu G; Wang H; Tang C; Yang G; Xu Y
    Dis Markers; 2022; 2022():4761803. PubMed ID: 35655917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
    Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
    PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.
    Pang JS; Li ZK; Lin P; Wang XD; Chen G; Yan HB; Li SH
    Oncol Rep; 2019 Apr; 41(4):2089-2102. PubMed ID: 30816528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear-cell renal cell carcinoma.
    Zhang Y; Chen Z; Chen JG; Chen XF; Gu DH; Liu ZM; Gao YD; Zheng B
    FEBS Open Bio; 2021 Nov; 11(11):2988-3004. PubMed ID: 34449964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Prognostic Markers of DNA Damage and Oxidative Stress in Diagnosing Papillary Renal Cell Carcinoma Based on High-Throughput Bioinformatics Screening.
    Li L; Liu X; Wen Y; Liu P; Sun T
    J Oncol; 2023; 2023():4640563. PubMed ID: 36785669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
    Luo L; Zhou H; Su H
    BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
    Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D
    BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.
    Bai J; Pu X; Zhang Y; Dai E
    Ren Fail; 2022 Dec; 44(1):966-986. PubMed ID: 35713363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key genes and signalling pathways in clear cell renal cell carcinoma: An integrated bioinformatics approach.
    S V; Balasubramanian S; Perumal E; Santhakumar K
    Cancer Biomark; 2024; 40(1):111-123. PubMed ID: 38427469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FMR1 is identified as an immune-related novel prognostic biomarker for renal clear cell carcinoma: A bioinformatics analysis of TAZ/YAP.
    Wu S; He H; Huang J; Jiang S; Deng X; Huang J; Chen Y; Jiang Y
    Math Biosci Eng; 2022 Jun; 19(9):9295-9320. PubMed ID: 35942760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Hub Genes and Pathways in a Rat Model of Renal Ischemia-Reperfusion Injury Using Bioinformatics Analysis of the Gene Expression Omnibus (GEO) Dataset and Integration of Gene Expression Profiles.
    Guo A; Wang W; Shi H; Wang J; Liu T
    Med Sci Monit; 2019 Nov; 25():8403-8411. PubMed ID: 31699960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation.
    Feng X; Zhang M; Meng J; Wang Y; Liu Y; Liang C; Fan S
    Oncol Res; 2020 May; 28(3):285-297. PubMed ID: 31948514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic Analysis Combined With Experimental Validation Reveals Novel Hub Genes and Pathways Associated With Focal Segmental Glomerulosclerosis.
    Hou YP; Diao TT; Xu ZH; Mao XY; Wang C; Li B
    Front Mol Biosci; 2021; 8():691966. PubMed ID: 35059432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.